Physician profile
David Moisan
NPI 1003424367
$2,121.77
in general payments reported to CMS, 2019-2025
20 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $414 · 2022: $538 · 2023: $726 · 2024: $222 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,170.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $397.47 | 2021-2024 | Breztri |
| Novo Nordisk INC | $318.13 | 2022-2024 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $311.85 | 2021-2023 | Trelegy Ellipta |
| Abbott Laboratories | $194.09 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Nuvasive, INC. | $146.00 | 2022 | |
| Incyte Corporation | $125.13 | 2025 | Monjuvi |
| Sobi, INC | $125.00 | 2024 | |
| Amarin Pharma, INC. | $88.46 | 2021 | |
| Allergan, INC. | $78.20 | 2021-2022 | |
| Lilly USA, LLC | $67.06 | 2021-2025 | Mounjaro |
| Kowa Pharmaceuticals America, INC. | $61.46 | 2021 | |
| Bausch Health US, LLC | $47.91 | 2021-2022 | |
| Kyowa Kirin, INC. | $29.61 | 2025 | |
| Novartis Pharmaceuticals Corporation | $22.25 | 2025 | |
| Exact Sciences Corporation | $22.04 | 2024 | Cologuard Collection Kit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $20.79 | 2024 | Inspire |
| Lundbeck LLC | $20.02 | 2022 | |
| Gilead Sciences, INC. | $18.60 | 2025 | Trodelvy |
| Abbvie INC. | $13.89 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.81 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Moisan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.